Skip to main content
logo
Solara Active Pharma Sciences Limited (NSE:SOLARA)
India flag India · Delayed Price · Currency is INR
515.00
+7.00 (1.38%)
Jul 31, 2026, 3:29 PM IST

NSE:SOLARA Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
14,31413,69012,83812,88914,43812,683
Revenue Growth
15.49%6.64%-0.40%-10.73%13.84%-21.56%
Gross Profit
6,9706,8456,2314,2616,0495,605
Operating Income
888.9870.71,081-1,975275.9-259.9
Net Income
-16.2-74.15.4-5,674-221.8-581.5
Earnings Per Share
-0.36-1.680.14-148.51-6.16-16.18
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
533.4533.439.584.487.3463.8
Total Debt
6,8666,8667,96110,11510,12910,374
Net Cash (Debt)
-6,332-6,332-7,921-10,031-10,041-9,910
Net Cash Growth
------
Net Cash Per Share
-140.72-143.56-198.52-262.55-278.95-275.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-1,5292,1281,0891,563-2,420
Capital Expenditures
--528.2-399.4-410.6-1,113-2,086
Free Cash Flow
-1,0011,729678.1449.4-4,507
Free Cash Flow Growth
--42.10%154.95%50.89%--

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
48.69%50.00%48.54%33.06%41.90%44.19%
Operating Margin
6.21%6.36%8.42%-15.33%1.91%-2.05%
Pretax Margin
-0.11%-0.54%0.04%-37.89%-3.10%-7.18%
Profit Margin
-0.11%-0.54%0.04%-44.02%-1.54%-4.58%
FCF Margin
-7.31%13.47%5.26%3.11%-35.53%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--4566.82---
Forward PE
-13.0917.8027.2533.3322.46
P/FCF Ratio
24.7220.4814.2719.6926.23-
PS Ratio
1.731.501.921.040.821.89